ReviewCureus2026
Epigenomics and Ayurgenomics: Molecular Analysis of Ayurvedic Prakriti in Personalized Healthcare.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Personalized healthcare increasingly requires models that explain individual variation in disease risk, prevention, and treatment response. Ayurvedic Prakriti offers a constitution-based framework for classifying human variability through Vata, Pitta, and Kapha phenotypes, while Ayurgenomics attempts to connect these traditional classifications with molecular biology. Despite growing interest, the biological relationship between Prakriti, epigenomic regulation, and precision healthcare remains insufficiently established, particularly because available evidence is limited by small cohorts, heterogeneous assessment tools, and incomplete biomarker validation. This review examines the molecular relevance of Prakriti by analyzing evidence from genomics, epigenomics, transcriptomics, proteomics, metabolomics, pharmacogenomics, and systems biology. Literature was evaluated thematically to identify constitution-specific molecular signatures, disease susceptibility patterns, lifestyle-related epigenetic influences, and translational applications in individualized healthcare. Current findings suggest that Prakriti types may be associated with distinct biological profiles involving metabolism, inflammation, immune regulation, oxidative stress, stress adaptation, and drug response. Epigenomic mechanisms may further explain how diet, lifestyle, environment, aging, and stress modify gene expression within constitution-specific contexts. Integrating Ayurgenomics with multi-omics platforms may support preventive screening, personalized nutrition, lifestyle planning, and precision therapeutics. Stronger validation through standardized tools, longitudinal studies, and clinical trials remains essential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.